Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
Last August, a riveted world watched a drama unfold in northern Chile. Thirty-three men were entombed half-a-mile underground when the San Jose copper mine collapsed. A rock the size of a skyscraper had sheared off the mountain above and blocked the miners’ access to the surface. After seventeen days — as hopes for their survival began to dim — the men were discovered alive. For seven weeks, engineers and emergency workers worked around the clock to bring the men to the surface. One American journalist gained exclusive access to the rescue operation and the trapped miners. This hour, he tells the story of their dramatic ordeal and its aftermath.
- Jonathan Franklin award-winning journalist who reports for "The Washington Post," "The Guardian," and "Der Spiegal," among other publications. He lives in Santiago, Chile.
Read an Excerpt
60 Minutes recently interviewed several of the 33 Chilean miners about the many challenges they are facing in the aftermath of their rescue:
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.